| Dr Thaddeus Alexas Ray, DO | |
|
4601 E Broadway Blvd, Tucson, AZ 85711-3511 | |
| (520) 399-6000 | |
| Not Available |
| Full Name | Dr Thaddeus Alexas Ray |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 4601 E Broadway Blvd, Tucson, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679535298 | NPI | - | NPPES |
| 470441 | Medicaid | AZ | |
| 7129724 | Other | NM | AETNA |
| 89731034 | Medicaid | NM | |
| P00896733 | Other | NM | R R MEDICARE |
| 202039285 | Other | NM | PRESBYTERIAN HEALTH PLAN |
| 11553251 | Medicaid | CO | |
| 1679535298 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | A-1463-08 (New Mexico) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 010355 (Arizona) | Primary |
| Entity Name | Emil H Annabi Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245635390 PECOS PAC ID: 0941511109 Enrollment ID: O20150616002315 |
News Archive
A team of scientists at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Jean-Fran-ois C-t-, Director of the Cytoskeletal Organization and Cell Migration research unit, identified a novel molecular mechanism in the control of cell motility. Their findings were published online today in Current Biology, a journal from the Cell Press group. This scientific breakthrough could eventually lead to the development of new cancer-treating drugs that could block the spread of tumours (metastasis).
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.
A large-scale international study involving French researchers from the Inserm-Institut Pasteur Lille-Universit- Lille Nord de France "Public health and molecular epidemiology of ageing-related diseases" joint research unit led by Philippe Amouyel, has just discovered a gene for susceptibility to a rare disease that causes susceptibility to a common one, Alzheimer's disease, providing evidence of the heterogeneous aetiology of Alzheimer's disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thaddeus Alexas Ray, DO 6263 N Via Jaspeada, Tucson, AZ 85718-3392 Ph: (505) 215-2488 | Dr Thaddeus Alexas Ray, DO 4601 E Broadway Blvd, Tucson, AZ 85711-3511 Ph: (520) 399-6000 |
News Archive
A team of scientists at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Jean-Fran-ois C-t-, Director of the Cytoskeletal Organization and Cell Migration research unit, identified a novel molecular mechanism in the control of cell motility. Their findings were published online today in Current Biology, a journal from the Cell Press group. This scientific breakthrough could eventually lead to the development of new cancer-treating drugs that could block the spread of tumours (metastasis).
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.
A large-scale international study involving French researchers from the Inserm-Institut Pasteur Lille-Universit- Lille Nord de France "Public health and molecular epidemiology of ageing-related diseases" joint research unit led by Philippe Amouyel, has just discovered a gene for susceptibility to a rare disease that causes susceptibility to a common one, Alzheimer's disease, providing evidence of the heterogeneous aetiology of Alzheimer's disease.
› Verified 1 days ago
Sheldon E Gingerich, MD Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 630 N Alvernon Way, Tucson, AZ 85711 Phone: 520-322-8440 Fax: 520-322-8462 | |
Stephen Allen Shiller, Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 N. Campbell Ave., Tucson, AZ 85724 Phone: 520-626-0887 | |
Dr. Jose M. Chavez, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1704 W Anklam Rd Ste 108, Tucson, AZ 85745 Phone: 623-516-8252 Fax: 623-516-8253 | |
Kyung Jang Chen, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 5301 E. Grant Rd., Orthopaedic Bldg, 1st Floor, Tucson, AZ 85712 Phone: 520-784-6200 Fax: 520-784-6109 | |
Ms. Johnna Gigi Hayse, FNP-C Pain Medicine Medicare: Medicare Enrolled Practice Location: 7494 N La Cholla Blvd, Tucson, AZ 85741 Phone: 520-395-0512 Fax: 520-505-4108 |